BRIEF: Cloudbreak tumbles in Hong Kong trading debut
Ophthalmic biotech company Cloudbreak Pharma Inc. (2592.HK) opened down 6% in its Hong Kong trading debut on Wednesday, and continued to fall during the morning session to close down 30% at HK$7.04…
BRIEF: Cloudbreak launches $78 million Hong Kong IPO
Ophthalmic biotech company Cloudbreak Pharma Inc. (2592.HK) launched its Hong Kong IPO on Tuesday, aiming to sell 60.58 million shares at HK$10.10 apiece to raise about HK$610 million ($78 million). Share…
Recent Articles
RELATED ARTICLES
-
BRIEF: Cloudbreak launches $78 million Hong Kong IPO
2592.HK
-
After a failed Fosun buyout, what’s next for drug maker Henlius Biotech?
2696.HK
-
BRIEF: MetaLight tumbles in Hong Kong trading debut
2605.HK
-
BRIEF: CaoCao tumbles in Hong Kong trading debut
2643.HK
-
BRIEF: Duality Biotherapies surges in Hong Kong trading debut
9606.HK
-
BRIEF: Saimo Technology ticks up in Hong Kong trading debut
2571.HK
